Key terms
About XLO
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest XLO news
No recent news articles are available for XLO
No recent press releases are available for XLO
XLO Financials
Key terms
Ad Feedback
XLO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
XLO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range